BIAlert Sepsis obtains CE marking as a medical device
Home News BIAlert Sepsis obtains CE marking as a medical device

BIAlert Sepsis obtains CE marking as a medical device

JUNE 19, 2024 BHH Members Initiatives

Artificial Intelligence opens up new possibilities for early and personalised care for sepsis, a time-dependent condition with a 32-50% mortality rate. The Instituto de Ingeniería del Conocimiento (IIC) has been working for some time on an intelligent alert system: BIAlert Sepsis, which has just become the first Spanish AI for sepsis prediction to obtain CE marking (level IIa).

Granted by Intertek Medical Notified Body AB, a body notified by the EU, this certificate guarantees it as a medical device in accordance with the requirements of quality, safety, efficacy and correct information required by EU directives and the Spanish Agency for Medicines and Medical Devices (AEMPS) for its commercialisation.

In this way, BIAlert Sepsis has gone from being a research project to becoming a validated tool in healthcare practice and has already been demonstrating its efficacy for two and a half years at the Hospital Universitario Son Llàtzer in Palma de Mallorca. Here it has been shown to predict the risk of sepsis 24 hours in advance and with a predictive capacity of 96%, after being trained on data from more than 200,000 Spanish patients.What does

BIAlert Sepsis bring to the healthcare sector?

Given the complexity of sepsis diagnosis, which is highly variable and depends on different patient conditions, artificial intelligence could support the medical professional and complement the Sepsis Code already implemented in 170 Spanish hospitals.

BIAlert Sepsis combines medical knowledge with AI techniques that infer new sepsis cases after analysis of historical medical data, reducing the high false positive and false negative rates (65%) of protocols. For example, at Hospital Universitario Son Llàtzer, up to 200 new cases of sepsis have been identified in one year that would not have been detected if only the medical rules had been applied.

In practice, BIAlert Sepsis runs on the hospital's updated data, automatically uploading it from the medical record without generating additional work for the practitioner. It collects information every 30 minutes from each admitted patient and issues an alert or recommendation if it detects a possible sepsis, for the clinician to assess and validate. It is based on the analysis of up to 200 clinical variables relevant to the diagnosis.

"It is a small revolution in what we were doing until now, which we knew was not enough, as we had not been able to identify sepsis early. Now we no longer have to wait for the first organic dysfunctions to appear," stresses Marcio Borges, coordinator of the hospital's Multidisciplinary Sepsis Unit, member of the IdISba Sepsis Group and president of the Sepsis Code Foundation.

Development and adaptation of BIAlert Sepsis

In 2018, the Instituto de Ingeniería del Conocimiento (IIC) began working on the algorithm with the Hospital Universitario Son Llàtzer, following a tender launched by the Fundación Instituto de Investigación Sanitaria Illes Balears (IdISBa). Within the framework of a research project, BIAlert Sepsis was developed in two phases.

First, a retrospective analysis of the historical data of 200,000 patients was carried out. From this medical information, the determinant variables for the prediction of sepsis were identified and the Machine Learning model was trained.

Then, in the prospective phase, the model was tested and validated, proving that it was capable of alerting the medical team in real time of possible cases of sepsis. This is where the tool adapts to the casuistry of each hospital: "Sepsis is not defined in the same way in all healthcare facilities. It is essential to collaborate with the medical team to carry out this local adaptation. If we want the tool to be accurate, we need to personalise and customise," explains Elisa Martín, director of the Health Predictive Analytics area of the Instituto de Ingeniería del Conocimiento (IIC).

BIAlert Sepsis is designed to be integrated into the clinical practice and dynamics of each hospital. According to the IIC methodology, the adaptation of the tool requires the knowledge and trust of the medical team, which supervises the process and validates the results of the models, while at the same time seeing that the tool can add value to their work. Already in practice, the decision of the medical specialist remains the only valid one, the system only suggests to review the data of a given patient, with a high probability of developing sepsis, in order to act more quickly.

How is BIAlert Sepsis implemented in a hospital?

The experiences and tests, both technical and clinical, carried out with BIAlert Sepsis have served to support the CE marking that certifies it as a medical device. Now, following its integration at the Hospital Universitario Son Llàtzer, two other hospitals, the 12 de Octubre in Madrid and the Complejo Hospitalario Universitario de Albacete, are incorporating this AI software into their patient management systems. All of them have had or will have to follow a series of steps to do so:

  1. It must be approved by the hospital's ethics committee.
  2. A data protection / confidentiality agreement is signed.
  3. All you need is a server, which any centre can have, with a computer with some memory (nothing exceptional).
  4. A dictionary is developed for standardised labelling of clinical criteria in each hospital. It does not generate additional work for the professional.
  5. It is installed remotely and a remote check is also carried out to confirm that everything is OK.
  6. The system reads data from the patient's medical record every 30 minutes at the most, although readings can be programmed up to every 15 minutes.
  7. The system issues an alert when there is a significant chance that the patient will develop sepsis in the next 24 hours.
  8. The medical team tests the patient for the pathogen that will cause sepsis.
  9. The patient receives medication to prevent sepsis.

Because of data protection law, the hospitals cannot share data with each other, but the algorithm is learning more and more from experience, so its effectiveness can only increase, providing ever more accurate predictions. BIAlert Sepsis is a technological solution made in Spain that can change the paradigm of sepsis management and realize the promise of the application of AI in healthcare.

December 20, 2024 BHH Members Initiatives
Join the Pallapupas Christmas Raffle and bring smiles to Hospitals
By joining this raffle, participants will directly support a cause that uplifts the lives of patients and families when they need it most
Read more
December 17, 2024 BHH Members Initiatives
Join the Metastasis Challenge to find a cure for cancer
This initiative calls society to action in the fight against metastasis.
Read more
December 17, 2024 BHH Members Initiatives
Support hospitals with meaningful gifts this Christmas
In a year filled with challenges, what better way to embrace the holiday spirit than by choosing gifts with a purpose?
Read more
December 16, 2024 BHH Members Initiatives
Join the Tech4Eva 2025 Call for Application
Join the growing Femtech community of Tech4Eva and apply to this 6-month game changing global and virtual accelerator starting in May 2025
Read more
December 12, 2024 BHH Members Initiatives
Imaginae is transforming healthcare with AI and end-to-end digital solutions
Imaginae’s offerings include expertise in cloud solutions and IoT (Internet of Things), focusing on connected devices for eHealth.
Read more
December 11, 2024 BHH Members Initiatives
Maximizing the Potential of Remote Talent: Management, Communication, and Cultural Diversity
In a world where global connectivity is more accessible than ever, companies have the opportunity to tap into a borderless talent market.
Read more
December 03, 2024 BHH Members Initiatives
Barça Innovation Hub joins Genomcore shareholders
Barça Innovation Hub (BIHUB) co-invests alongside US-based investment firm QVIDTVM to support Genomcore’s expansion in biomedical data management and sports innovation.
Read more
November 25, 2024 BHH Members Initiatives
VB Devices expands its international presence with VARIXIO to over 30 countries
VB Devices will have expanded its international presence with VARIXIO to over 30 countries by the end of 2024. 
Read more
November 18, 2024 BHH Members Initiatives
Virtuleap launches Cogniclear VR for early cognitive screening
Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.
Read more
November 13, 2024 BHH Members Initiatives
Participate in the lottery to mitigate pharmaceutical poverty
Once again Banco Farmacéutico sells lottery tickets in order to mitigate pharmaceutical poverty.
Read more